about
Role of alcohol metabolism in non-alcoholic steatohepatitisEffect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob miceNonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsHepatic steatosis: a benign disease or a silent killerDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisWeight reduction for non-alcoholic fatty liver diseaseWeight reduction for non-alcoholic fatty liver diseaseDrugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitisNonalcoholic fatty liver diseaseExendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob miceTreatment of non-alcoholic fatty liver diseaseRedox mechanisms in hepatic chronic wound healing and fibrogenesisAssociation between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyMeasurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis.Micronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseRole of NLRP3 Inflammasome in the Progression of NAFLD to NASHThe Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundNovel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver HomeostasisInsulin resistance in development and progression of nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease as a multi-systemic diseaseGut Microbiota and Lifestyle Interventions in NAFLDAutophagy: a new target for nonalcoholic fatty liver disease therapyHepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesThe Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseResveratrol Inhibition of Cellular Respiration: New Paradigm for an Old MechanismHepatocellular carcinoma and non-alcoholic steatohepatitis: The state of playGlycosyltransferases and non-alcoholic fatty liver diseaseUse of fibrates in the metabolic syndrome: A reviewBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeNutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseMechanisms of intrahepatic triglyceride accumulationOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineThe Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and ProgressionAnimal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameTreatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight LossBile acid receptors and nonalcoholic fatty liver diseaseDoes Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?Endocrine causes of nonalcoholic fatty liver diseaseThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
P2860
Q21142633-0ABE1213-BDB6-43FE-A15D-F18ABB9204C8Q21245690-3FE69C23-8EC8-4457-AC40-9A8789B8C31DQ22299426-737E7FCB-24E6-48D9-877F-1CCE2DD5048CQ22305506-338D051E-EE67-4F7A-90D8-229CB5783E9CQ24197984-59EAC740-ACC1-4FA5-BCA2-4B670E1BCCC1Q24198072-78FC9F2A-2626-4B3E-B84E-16E1271C8D0FQ24235200-029C43B0-4F34-4F46-9776-C66529CCF340Q24236500-4194A6FB-691A-4F2E-9FA0-8EFF4ABB6DDFQ24246447-8C94E6C1-0CBE-42EB-BEDA-329384510022Q24555779-B120F954-96E0-4C1B-806A-D53769F7F1A4Q24629441-CE6CB3B1-1171-4A82-9E2B-0ADA9A4A84BFQ24655572-BA8EBA54-B50B-47D1-BDF7-928658C4F7F7Q24656684-5C160A6A-BF70-4B2D-B934-BF0505523732Q24658538-21CB6F86-0085-4FEF-8E01-99A5C4156B2AQ24815160-C7B7B441-B268-49EC-BC84-D9EE3C5067F3Q26738646-11305EC0-6334-4C98-9E54-B1E85E94315EQ26742102-06A9D6F8-4100-4EDD-A0F5-B728CAA53740Q26744380-5BB1D19C-BECF-4708-B782-387B88816967Q26746997-85EB8A14-D623-40BF-B3B9-F0BA46AC9E06Q26748687-3F527513-E0A2-48D1-BE21-BB0915E6C8E2Q26749290-C9E1AA9D-A901-4741-9479-9001FF2F7026Q26749783-8A71B976-B05B-4F33-9D26-D5C149BE01E9Q26751326-C0F56948-06D7-417A-8514-D221A6FF5DF6Q26752622-74258C47-263E-4FEE-8414-DB99BF426BD6Q26752762-42EA4B37-92C4-4CBB-A66D-DD04AA9D51F5Q26753034-7F7DCE38-2CB4-4F89-8D7C-42546A6EB0ADQ26764911-B1DF0AA5-CF4F-4372-8719-A7799CF06CADQ26764913-DDAD81A1-8BD6-449B-BA4E-B79DC39A77FCQ26765234-5C30D93F-FCEF-4027-8AAC-D5161C19A203Q26765455-A4ADDC06-E188-4023-A9DA-B8E69B5970FDQ26771752-BC9C7309-DA7D-4275-B7D9-4D4F1101F85FQ26773198-E81842C2-230D-4094-BFB2-A2FC2C0475E6Q26773384-DC8A595C-B6E4-4826-9129-40040C75BD67Q26775025-FC3DFE1D-080B-4727-B419-A8CF9E4CF5CFQ26775571-A4829625-BAB8-4AE2-9653-5D6030844BF0Q26775632-B3C615B8-AF4D-4713-9E10-58B9A4B23D0BQ26775814-9D651790-8DAE-4DD6-8505-8FB4CFD0BEA9Q26776043-50D84B94-79E9-4322-A668-1D5D2A858A3FQ26780254-1890D4A2-5265-4F0C-931E-DE593A0ED033Q26780509-F24F0F52-FFB1-45D2-9DCE-36D677C4EC9B
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Steatohepatitis: a tale of two "hits"?
@ast
Steatohepatitis: a tale of two "hits"?
@en
type
label
Steatohepatitis: a tale of two "hits"?
@ast
Steatohepatitis: a tale of two "hits"?
@en
prefLabel
Steatohepatitis: a tale of two "hits"?
@ast
Steatohepatitis: a tale of two "hits"?
@en
P3181
P1433
P1476
Steatohepatitis: a tale of two "hits"?
@en
P3181
P356
10.1016/S0016-5085(98)70599-2
P407
P577
1998-04-01T00:00:00Z